Prevalence of Phonophobia and Cutaneous Allodynia in Episodic Migraineurs
NCT00386880 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 38
Last updated 2014-08-22
Summary
Cutaneous allodynia is an increased skin sensitivity experienced during a headache. It has been noted in several studies that in patients with migraine, seventy nine percent of the patients experienced allodynia on the facial skin on the same side as the headache. Understanding more about the occurrence of phonophobia (increased sensitivity to sound) and allodynia may help us understand how the pain system works in migraine. It is hoped that the knowledge gained from this trial may enable us to more effectively treat patients with migraine headache.
Conditions
Interventions
- OTHER
-
Sounds
Sponsors & Collaborators
-
Thomas Jefferson University
lead OTHER
Principal Investigators
-
Abraham A. Ashkenazi, M.D. · Thomas Jefferson University
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-08-31
- Primary Completion
- 2007-08-31
- Completion
- 2007-09-30
Countries
- United States
Study Locations
More Related Trials
-
Transcutaneous Auricular Vagus Nerve Stimulation for Meniere Disease
NCT05328895 ·Status: COMPLETED ·Phase: NA
-
Magnetic Resonance Imaging Evaluation of Inner Ear Pathology Using Intra-Tympanic Contrast Agent
NCT02080312 ·Status: COMPLETED ·Phase: NA
-
OTO-313 in Subjects With Unilateral Subjective Tinnitus
NCT04829214 ·Status: COMPLETED ·Phase: PHASE2
-
The SeaSHeL National Prospective Cohort Study
NCT04108598 ·Status: UNKNOWN
-
Comparison of 3 Methods to Diagnose Endolymphatic Hydrops in Meniere's Disease
NCT03215420 ·Status: COMPLETED ·Phase: NA
-
TNF-α Treatment of Blast-Induced Tinnitus
NCT04066348 ·Status: RECRUITING ·Phase: PHASE2
-
Treatment of Meniere's Disease With Migraine Medications
NCT05582837 ·Status: RECRUITING ·Phase: PHASE4
-
Transcutaneous Auricular Vagus Nerve Stimulation Treatment on Meniere Disease
NCT04686695 ·Status: COMPLETED ·Phase: NA
-
Repurposed Use of Allergic Rhinitis and Allergic Asthma Drug to Reduce Vertigo and Hearing Loss in Meniere's Disease
NCT04815187 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
A Study Of The Effects Of PF-04958242 In Subjects With Age-Related Hearing Loss
NCT01518920 ·Status: COMPLETED ·Phase: PHASE1
-
OTO-313 in Subjects With Subjective Tinnitus
NCT03918109 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Assesment of Hearing in Patients With Vestibular Migra
NCT05396482 ·Status: UNKNOWN
-
Effectiveness of Integrative Medical Treatment in Sudden Hearing Loss
NCT07235488 ·Status: RECRUITING ·Phase: NA
-
Autoimmunity in Inner Ear Disease
NCT00000361 ·Status: TERMINATED ·Phase: PHASE3
-
Gastrodin Acupoint Injection for Sensorineural Hearing Loss With Vertigo
NCT07283562 ·Status: COMPLETED ·Phase: NA
-
Prevalence of Peripheral Neuropathy Among Patients With Auditory Neuropathy
NCT06041360 ·Status: UNKNOWN
-
Is There Hearing Loss After Acute Mastoiditis
NCT00502450 ·Status: WITHDRAWN
-
Ear Acupuncture for Acute Sore Throat in Patients Unable to Take Non-steroidal Anti-inflammatory Agents (NSAIDs)
NCT01301482 ·Status: TERMINATED ·Phase: NA
-
Study of OTO-104 in Subjects With Unilateral Meniere's Disease
NCT02612337 ·Status: COMPLETED ·Phase: PHASE3
-
OTO-413 in Subjects With Speech-in-Noise Hearing Impairment
NCT04129775 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Evaluating Possible Improvement in Tinnitus Severity After 28 Days Dosing of the Study Drug AUT00063 Compared to Placebo
NCT02315508 ·Status: COMPLETED ·Phase: PHASE2
-
Assessing the Efficacy of a Serotonin and Norepinephrine Reuptake Inhibitor for Improving Meniere's Disease Outcomes
NCT04218123 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Validating and AI Software for Assessment of Children With Ear Concerns
NCT07243093 ·Status: NOT_YET_RECRUITING
-
A Study of a Mastoid Device in Subjects With Ménière's Disease
NCT03520322 ·Status: TERMINATED ·Phase: NA
-
Study of Lamotrigine to Treat Ménière's Disease
NCT02158585 ·Status: COMPLETED ·Phase: PHASE2